Despite the identified dual functionality of c-FLIPL as a pro- or antiapoptotic factor in normal tissues, c-FLIPL has generally been shown to act as a key negative regulator of apoptosis in human cancer cells [38, 39]. This evidence concerns the gene CFLAR and cancer.